ScreenerHero

OPRXOptimizeRx Corporation

NAS · US · Healthcare · Health Information Services · optimizerx.com
7.710USD-3.75%Mkt Cap: 145.23M $P/E: 30.84

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Mi…

Industry Peers

Health Information Services
Screen all
VEEV
Veeva Systems Inc Class A
$40.27BUSDP/E 44.0
TEM
Tempus AI Inc. Class A Common Stock
$13.12BUSD
BTSG
BrightSpring Health Services Inc. Common Stock
$11.65BUSDP/E 52.6
HQY
HealthEquity, Inc.
$8.84BUSDP/E 39.5
TXG
10x Genomics, Inc.
$8.48BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.80BUSDP/E 35.7
DOCS
Doximity Inc. Class A Common Stock
$4.51BUSDP/E 30.2
HTFL
Heartflow Inc. Common Stock
$4.33BUSD
PRVA
Privia Health Group, Inc.
$2.70BUSDP/E 96.0
OMCL
Omnicell, Inc.
$1.62BUSDP/E 42.4
SDGR
Schrödinger, Inc.
$1.47BUSD
OMDA
Omada Health Inc. Common Stock
$1.46BUSDP/E 35.7
CERT
Certara, Inc.
$1.29BUSD
GDRX
GoodRx Holdings, Inc.
$1.18BUSDP/E 57.5
TDOC
Teladoc Health, Inc.
$1.16BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$844.16MUSDP/E 40.1
PHR
Phreesia, Inc.
$748.70MUSDP/E 75.8
SOPH
SOPHiA GENETICS SA Ordinary Shares
$736.36MUSD
HeadlineSourceTime
Older
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

AI software revenue grew 25% despite overall quarterly decline from customer inactivity.

Motley Fool
OptimizeRx Corporation Q2 2026 Earnings Call Summary

Moby summary of OptimizeRx Corporation's Q2 2026 earnings call

Moby
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

Despite a 30% revenue decline, OptimizeRx Corp (OPRX) reaffirms full-year guidance, driven by AI-powered product growth and a strengthened balance sheet.

GuruFocus.com
OptimizeRx Q2 Earnings Call Highlights

OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its earnings call. The company reaffirmed its full-year revenue outlook of $95 million to $100 million and

MarketBeat
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

OptimizeRx (OPRX) delivered earnings and revenue surprises of +45.46% and +0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
PTC Inc. (PTC) Q3 Earnings and Revenues Miss Estimates

PTC Inc. (PTC) delivered earnings and revenue surprises of -1.25% and -2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Commvault Systems (CVLT) Beats Q1 Earnings and Revenue Estimates

Commvault (CVLT) delivered earnings and revenue surprises of +20.34% and +0.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Pegasystems (PEGA) Lags Q2 Earnings and Revenue Estimates

Pegasystems (PEGA) delivered earnings and revenue surprises of -18.61% and -1.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations
Simply Wall St.
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust
GuruFocus.com
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
Zacks